Lupus Ontario Symposium 2024 – Redefining The Lupus Landscape
October 22, 2024 @ 7:00 pm – October 23, 2024 @ 9:00 pm
SESSION 1: 22nd October, 7-8PM EST,
EULAR Guideline Revisions
In this session, Dr. Laura Whitthall Garcia will delve into the European Alliance of Associations for Rheumatology (EULAR) and its crucial role in setting guidelines for lupus. She will discuss the current EULAR guidelines for lupus, recent changes to these guidelines, and the reasons behind these updates. Additionally, the session will explore how these guidelines are applied in diagnosing and treating lupus to ensure effective and standardized patient care.
SESSION 2: 22nd October, 8-9PM EST
Lupus Types Expanded
In this session, Dr. Murray Urowitz will provide a brief recap of Types 1 and 2 lupus, followed by an in-depth exploration of lupus types 3, 4, and beyond. He will discuss the implications of these classifications on ongoing lupus patient treatment and provide insights on how patients can effectively advocate for themselves as their disease evolves. The session aims to equip lupus patients with the knowledge and strategies to engage proactively with their care practitioners.
SESSION 3: 23rd October, 7-8PM EST
Biologics Explained
In this session, Dr. Amanda Steiman will demystify biologics by explaining what they are and how they function in treating diseases. She will highlight the differences between biologics and other treatment options, detailing how patients should prepare for biologic treatment, including necessary tests, vaccines, and potential side effects. Additionally, Dr. Steiman will compare infusion and subcutaneous methods, providing guidance on what patients can expect from each approach.
SESSION 4: 23rd October, 8-9PM EST
CAR T-Cell Therapy and Upcoming Treatments
In this session, Dr. Mark Matsos will provide an overview of emerging treatments for lupus, with a focus on CAR T-Cell Therapy. He will explain the fundamentals of CAR T-Cell Therapy and discuss how this innovative approach could revolutionize the treatment landscape for lupus patients. The session will offer a glimpse into the future of lupus care, highlighting the potential benefits and transformative impact of these new therapies.